For This Family, AI Is The New Lemonade Stand
AI’s cavalcade of constraints. Uncovering a lost sacred manuscript. Why it’s okay to drink a little coffee before bed. All that and more in this week’s edition of The Prototype.
The search giant had previously created a machine learning data set out of food scraps from its kitchens. Now it’s partnering with Mill, which makes a high-tech trash bin, to use that data to train its AI algorithms.
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
Comparing Tesla and Rivian stock in 2026? See the analysis of these two companies to find the better investment for your portfolio needs.
This week’s Current Climate newsletter also looks at whether urbanists should embrace robotaxis and how the Middle East war may impact the renewable energy transition
Solving a century-old mystery about rubber. The space economy keeps booming. The physics of stir fry. All that and more in this week’s edition of The Prototype.
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them …
After watching engineers burn out from fixing late-night outages, Resolve AI CEO Spiros Xanthos is developing AI systems to ease the burden of being on call, backed by a new $40 million funding round.
Paris-based Mistral wanted to develop a top-tier AI model to rival OpenAI and Anthropic. That didn’t work out. But it turns out lots of folks don’t care if the AI is bleeding edge – as long as it wasn’t made in America or China.